Topics - Drug Development
Refine By
Content Type
FeaturesBreaking News
Columns
Editorial
Online Exclusives
Industry News
Industry Events
Buyers Guide Companies
Business Corner
Expert's Opinion
White Papers / Tech Papers
Classifieds
Services
Product Releases
Case Studies
Top Companies Report
Jobs
Videos
Collaborations & Alliances
Promotions & Movies
Trials & Filings
Financial Reports
Bio News & Views
Custom Sourcing News
Packaging & Tracking
Advanced Degrees
Financial Analysis
I Mak
Lowe Down
Managing Your Careeer
Pharma Beat
Preclinical Outsourcing
Salary Survey
Outsourcing Survey
Contracting & Outsourcing
Literature / Brochures
CRO News
FDA Watch
India Report
Executive Perspective
Ask The Board
Glossary
Posters
News Releases
Provider Survey
Conference Sessions
Ask The Experts
Published August 30, 2012
To develop and commercialize daratumumab Read More »
Published August 29, 2012
Analysis shows unlikely to meet efficacy endpoint Read More »
Published August 21, 2012
Ipsen gains rights in key territories, Inspiration to handle worldwide development Read More »
Published August 21, 2012
Expands personalized medicine offering Read More »
Published August 21, 2012
To develop and commercialize Ophthalmic therapies Read More »
Published August 16, 2012
To develop PI3K delta inhibitor Read More »
Published August 16, 2012
Aims to identify MS biomarkers for diagnostics Read More »
Published August 15, 2012
Regulus gets $28 million upfront for lead cardiovascular/metabolic program Read More »
Published August 15, 2012
To distribute osteogenic medium for research Read More »
Published August 6, 2012
Establishes R&D facility on Penn campus Read More »
By Gil Roth
Published July 31, 2012
Berkeley site includes bioreactors, purification suites Read More »
Published July 20, 2012
EU marketing licenses trigger $6 million payment Read More »
Published July 19, 2012
Triggers $8.5 million payment Read More »
